Heya, Im trying to solve a case study here. An overweight patient (BMI > 25) has experienced NSTEMI. He is now stabilized. The patient also has diabetes (type II) and renal failure. He is currently on biguanides. This is what I plan to give the patient for long term management of his heart failure:
Calcium channel blocker, nitrates, statins, aspirin, ace inhibitor
Will probably stop the biguanide as they are known to cause lactic acidosis in those with renal failure. Not sure what can I substitute it with? Surely not sulfonylureas because the patient is already obese.
You do not give enough information to make any reasonable suggestions.
What is his ejection fraction and what is his NYHA class of heart failure?
What is his Creatine in mg/dL and what is his creatinine clearance.
What other comorbid conditions does he have
and what are his medicine allergies.
personally, I wouldn't use a CCB and nitrate as first line therapy. It sounds like the info you've given that he doesn't have true renal failure, so an ACE-I and a diuretic should be first line in a Diabetic, if he has a depressed ejection fraction, then a beta-blocker is also warranted.
If he truly has renal failure, then a sulfonylurea is not a better choice than metformin, as they you are actually more likely to see side effects such as prolonged hypoglycemia since they're are cleared via renal, Amaryl (if I remember correctly) does have more hepatic clearance than the rest of the sulfonyureas, but I wouldn't use it in a pt I wouldn't be willing to use metformin.
If all he has is mild CKD, the NSTEMI (CAD) and DM, I'd put him on a diuretic, ACE-I, ASA, Statin combo metformin/sulfonyurea if he needs better control.
If he has worsening CKD which for diabetics with creatine over 2.0, metformin and sulfonyureas are out and leaves you with insulin, and if the heart failure is uncompensated or requires chronic diuretics, then metformin is also out again. I'm fine with using metformin in a well compensated CHF pt with a creatinine of 1.5, but have a low threshold for discontinuing it for insulin.